Switching from natalizumab to ocrelizumab in patients with multiple sclerosis. Levin SN, Ezuma C, Levine L, Vargas WS, et al. Mult Scler 2020 Jun 19:1352458520927631. doi: 10.1177/1352458520927631.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Levin SN, Ezuma C, Levine L, Vargas WS, et al. Switching from natalizumab to ocrelizumab in patients with multiple sclerosis. Mult Scler 2020 Jun 19:1352458520927631. doi: 10.1177/1352458520927631.
PMID: 32552363

Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016